Add to ORKGThe Present study aimed to improve the bioavailability of Rifampicin from fixed dose Combination with Isoniazid, Pyrazinamide and Ethambutal by Incorporating Rifampicin Nanoparticles with fixed dose Combinations. Rifampicin Nanoparticles were Prepared With different Concentrations of PLGA as Polymer and it was evaluated for its physico chemical parameters such as FTIR ,DSC, Entrapment Efficiency, Loading Capacity, In vitro drug release and In vivo pharmacokinetics. The percentage formation of its metabolite (3FRSV) also studied
Research Article published by Elsevier B.V.Poly-(dl-lactic-co-glycolic) acid (PLGA) nanoparticles we...
Objective: This research aims to validate the method for rifampicin analysis in plasma by using High...
Objective: This research aims to validate the method for rifampicin analysis in plasma by using High...
The aim of the present work was to minimize or prevent the degradation of rifampicin, the antituberc...
Previous study shows (or) reveals that ascorbic acid addition to plasma can prevent the decompositio...
Rifampicin is a naturally made, non-peptide antibiotic. It is bactericidal, killing by disabling the...
Background & Objectives: Poor bioavailability of rifampicin (R) in combination with other anti-tube...
Objective: The aim of the present study is to formulate and evaluate enteric coated pellets of Rifam...
Tuberculosis is a ubiquitous, highly contagious chronic granulomatous bacterial infection caused by ...
The pharmaceutical analysis defined as “the branch of practical chemistry which deals with the resol...
Sushruta S Hakkimane,1 Vishnu Prasad Shenoy,2 Santosh L Gaonkar,3 Indira Bairy,4 Bharath Raja Guru1,...
The present study was undertaken to compare in a cross-over design in both males and females, the b...
Salma M Mohyeldin, Mohammed M Mehanna, Nazik A Elgindy Department of Industrial Pharmacy, Faculty o...
Tuberculosis therapy remains a challenge even today, mainly due to the problems of bacterial resista...
The World Health Organization inspires the use of fixed dose combination (FDC) of rifampicin combina...
Research Article published by Elsevier B.V.Poly-(dl-lactic-co-glycolic) acid (PLGA) nanoparticles we...
Objective: This research aims to validate the method for rifampicin analysis in plasma by using High...
Objective: This research aims to validate the method for rifampicin analysis in plasma by using High...
The aim of the present work was to minimize or prevent the degradation of rifampicin, the antituberc...
Previous study shows (or) reveals that ascorbic acid addition to plasma can prevent the decompositio...
Rifampicin is a naturally made, non-peptide antibiotic. It is bactericidal, killing by disabling the...
Background & Objectives: Poor bioavailability of rifampicin (R) in combination with other anti-tube...
Objective: The aim of the present study is to formulate and evaluate enteric coated pellets of Rifam...
Tuberculosis is a ubiquitous, highly contagious chronic granulomatous bacterial infection caused by ...
The pharmaceutical analysis defined as “the branch of practical chemistry which deals with the resol...
Sushruta S Hakkimane,1 Vishnu Prasad Shenoy,2 Santosh L Gaonkar,3 Indira Bairy,4 Bharath Raja Guru1,...
The present study was undertaken to compare in a cross-over design in both males and females, the b...
Salma M Mohyeldin, Mohammed M Mehanna, Nazik A Elgindy Department of Industrial Pharmacy, Faculty o...
Tuberculosis therapy remains a challenge even today, mainly due to the problems of bacterial resista...
The World Health Organization inspires the use of fixed dose combination (FDC) of rifampicin combina...
Research Article published by Elsevier B.V.Poly-(dl-lactic-co-glycolic) acid (PLGA) nanoparticles we...
Objective: This research aims to validate the method for rifampicin analysis in plasma by using High...
Objective: This research aims to validate the method for rifampicin analysis in plasma by using High...